Sarepta Therapeutics hasn't moved too much today but is slightly down, it has lost -0.74% since yesterday. It looks like SRPT may be interacting with an upward sloping support line. These can create nice entry points since it can have both momentum and support. SRPT hasn't established a very clear directional momentum over the last few months. So it's not clear if it has the energy to break through or not.
If we get a reversal off of support and Sarepta Therapeutics starts moving up, it can probably get to $157.19 at which point it'll need to break through that resistance level in order to keep moving higher. There aren't very obvious support levels beneath this point. So put those stop losses on, this thing has room to fall if buyers don't come in at this level.
The analysts feel pretty optimistic about Sarepta Therapeutics and have been assigning positive ratings. The current Analysts Sentiment Score is 249.30. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Oppenheimer announced a lowering of their price target to $150.00 from $180.00 on 2023-03-09. JPMorgan Chase & Co. provided a price target boost of 34.64% to $206.00 from $153.00 on 2023-03-03. On 2023-03-01 Barclays increased their price target by 14.09% to $170.00. On 2023-03-01 Morgan Stanley upgraded Sarepta Therapeutics from Equal Weight to Overweight and moved up their price target to $187.00 which is a 32.62% increase. On 2023-03-01 The Goldman Sachs Group increased their price target by 11.11% to $190.00. On 2023-03-01 Credit Suisse Group increased their price target by 5.11% to $144.00. Robert W. Baird provided a price target boost of 32.89% to $202.00 from $152.00 on 2023-03-01. Royal Bank of Canada gave a boost to their price target and moved to $226.00 from $195.00 on 2023-03-01. Needham & Company LLC boosted their price targ by 25% to $200.00 on 2023-03-01. On 2023-01-20 there was confirmation of the previous rating by SVB Leerink which was Outperform and they set their price target at $160.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
SRPT | 249.30 | 160.43 | -0.45 | 367.18 | -28.57 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
SRPT | -5.33 | -5.20 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
SRPT | 7.51 | %7.93523 | 7.5 | -4.62 | 6910000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 354 | -0.27 | 1.80 | 2.84 | 13.34 | 13.88 | 15.81 | 58.77 | -14.14 | -10.57 | -9.88 | -28374.34 | -6755.49 | 3.67 | 3.88 | 6.63 | 51.67 |
Healthcare | 593 | -0.11 | 1.53 | 1.37 | 9.76 | 9.84 | 6.27 | 58.86 | -14.04 | -10.26 | -11.36 | -26226.85 | -6830.39 | 3.92 | 4.43 | 5.98 | 38.86 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
SRPT | 8.00 |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SGMO | Sangamo Therapeutics, Inc | 0.89 | -2.31 | 13.91 | 0.00 | -41.20 | -62.76 | -70.26 | 60 | -100.48 | -116.44 | -158.01 | -57224.06 | -1568.13 | 0 | 0 | 8.30077 |
INSM | Insmed, Inc. | 0.7 | 1.49 | 2.74 | 5.94 | 12.34 | 6.05 | 1.13 | 72 | -4.56 | -7.55 | -7.30 | -4906.69 | -5808.14 | 0 | 0 | 8.2465 |
IOVA | Iovance Biotherapeutics, | 0.68 | -3.03 | -9.20 | 6.53 | 17.16 | 10.13 | -12.58 | 41 | 5.21 | 7.45 | 6.45 | -13018.65 | -3854.94 | 0 | 0 | 9.55114 |
CDLX | Cardlytics, Inc. Common S | 0.68 | 1.32 | -6.13 | -10.07 | 58.11 | 28.85 | -81.50 | 45 | -15.44 | -29.55 | -12.80 | -63679.55 | -2770.99 | 0 | 0 | 8.41537 |
RARE | Ultragenyx Pharmaceutical | 0.67 | -0.46 | 1.44 | 9.49 | 26.64 | 30.55 | -5.17 | 76 | 12.31 | 13.75 | 10.57 | -800.17 | -11353.77 | 0 | 0 | 5.25037 |
MTLS | Materialise NV | 0.65 | -1.52 | -3.85 | 15.01 | 27.69 | 7.16 | -33.99 | 63 | 2.75 | -2.62 | -9.61 | -1236.49 | -3571.13 | 0 | 0 | 2.22986 |
UBER | Uber Technologies, Inc. | 0.65 | 3.32 | 4.54 | 3.89 | 24.79 | 52.59 | 55.96 | 66 | 43.41 | 55.09 | 60.71 | -212.95 | -30075.50 | 0 | 0 | 1.18638 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.